Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients

NCT02643862 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Food Allergy

Interventions

DRUG: Xolair
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]